FGFR2 Alterations in Endometrial Carcinoma

Modern Pathology - United Kingdom
doi 10.1038/modpathol.2011.110
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

CTCF Genetic Alterations in Endometrial Carcinoma Are Pro-Tumorigenic

Oncogene
Cancer ResearchGeneticsMolecular Biology
2017English

Prevention Strategies in Endometrial Carcinoma

Current Oncology Reports
Oncology
2018English

PI3K Inhibitors Synergize With FGFR Inhibitors to Enhance Antitumor Responses in FGFR2 Mutant Endometrial Cancers

Molecular Cancer Therapeutics
Cancer ResearchOncology
2017English

Expression of Bc-L2 in Precancerous Endometrial Lesion and Endometrial Carcinoma

Sohag Medical Journal
2019English

Pulmonary Metastasis From Endometrial Carcinoma

BMJ Case Reports
Medicine
2018English

Role of P14ARF Alterations in Endometrial Tumorigenesis a Mini-Review

Frontiers in Bioscience - Elite
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2012English

Ultrasound Diagnostics in Patients With Endometrial Carcinoma

Journal of Analytical Oncology
Cancer ResearchOncology
2012English

The Usefulness of Ultrasonography in Endometrial Carcinoma

Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
1992English

Expression of EZH2 in Endometrial Carcinoma and Its Effects on Proliferation and Invasion of Endometrial Carcinoma Cells

Oncology Letters
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy